Article thumbnail

Multiple Phenotypes in Adult Mice following Inactivation of the Coxsackievirus and Adenovirus Receptor (Car) Gene

By Ahmad Pazirandeh, Taranum Sultana, Momina Mirza, Björn Rozell, Kjell Hultenby, Karin Wallis, Björn Vennström, Ben Davis, Anders Arner, Rainer Heuchel, Matthias Löhr, Lennart Philipson and Kerstin Sollerbrant

Abstract

To determine the normal function of the Coxsackievirus and Adenovirus Receptor (CAR), a protein found in tight junctions and other intercellular complexes, we constructed a mouse line in which the CAR gene could be disrupted at any chosen time point in a broad spectrum of cell types and tissues. All knockouts examined displayed a dilated intestinal tract and atrophy of the exocrine pancreas with appearance of tubular complexes characteristic of acinar-to-ductal metaplasia. The mice also exhibited a complete atrio-ventricular block and abnormal thymopoiesis. These results demonstrate that CAR exerts important functions in the physiology of several organs in vivo

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3108585
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1983). A new approach to the induction of duct epithelial hyperplasia and nesidioblastosis by cellophane wrapping of the hamster pancreas.
  2. (2004). A role for the PDZ-binding domain of the coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth.
  3. (1993). A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development.
  4. (1997). Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment.
  5. (2002). beta-cell neogenesis during prolonged hyperglycemia in rats.
  6. (2008). Biological pacemaker engineered by nonviral gene transfer in a mouse model of complete atrioventricular block.
  7. (2005). CAR: a virus receptor within the tight junction.
  8. (2008). Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth.
  9. (2006). Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves.
  10. (2010). Cardiomyocytetargeted overexpression of the coxsackie-adenovirus receptor causes a cardiomyopathy in association with beta-catenin signaling.
  11. (2009). Coxsackie adenovirus receptor (CAR) regulates integrin function through activation of p44/42 MAPK.
  12. (2006). Coxsackievirus and adenovirus receptor (CAR) is expressed in male germ cells and forms a complex with the differentiation factor JAM-C in mouse testis.
  13. (2008). Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart.
  14. (2005). Coxsackievirus and adenovirus receptor is essential for cardiomyocyte development.
  15. (2007). Coxsackievirus and adenovirus receptor is up-regulated in migratory germ cells during passage of the blood-testis barrier.
  16. (2005). Coxsackievirus-adenovirus receptor (CAR) is essential for early embryonic cardiac development.
  17. (2004). Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.
  18. (1984). Development of experimental cancer in the head of the pancreas by surgical induction of tissue injury.
  19. (2001). Development of SHIRPA to characterise the phenotype of gene-targeted mice.
  20. (2000). Efficiency of adenovirusmediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression.
  21. (2002). Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
  22. (2000). Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis.
  23. (1999). Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density.
  24. (1999). Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells.
  25. (1999). Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats.
  26. (2003). Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
  27. (2007). Interaction of the Coxsackie and adenovirus receptor (CAR) with the cytoskeleton: binding to actin.
  28. (1981). Involution of the pancreas after ligation of the pancreatic ducts. I: a histological study.
  29. (2004). Isoform-specific expression of the Coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs.
  30. (2004). Junctional adhesion molecules (JAMs): more molecules with dual functions?
  31. (2005). Lineage tracing and characterization of insulin-secreting cells generated from adult pancreatic acinar cells.
  32. (2000). Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells.
  33. (2005). Neutrophil migration across tight junctions is mediated by adhesive interactions between epithelial coxsackie and adenovirus receptor and a junctional adhesion molecule-like protein on neutrophils.
  34. (2003). Origin and development of the precursor lesions in experimental pancreatic cancer in rats.
  35. (1982). Origin of tubular complexes in human chronic pancreatitis.
  36. (2006). Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation.
  37. (2006). Simultaneous dystrophin and dysferlin deficiencies associated with high-level expression of the coxsackie and adenovirus receptor in transgenic mice.
  38. (1998). Targeting of a short peptide derived from the cytoplasmic tail of the G1 membrane glycoprotein of Uukuniemi virus (Bunyaviridae) to the Golgi complex.
  39. (2005). The cell surface protein coxsackie- and adenovirus receptor (CAR) directly associates with the Ligand-of-Numb
  40. (2007). The Coxsackie and adenovirus receptor binds microtubules and plays a role in cell migration.
  41. (2006). The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis.
  42. (2003). The Coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX).
  43. (2004). The coxsackievirus and adenovirus receptor interacts with the multi-PDZ domain protein-1 (MUPP-1) within the tight junction.
  44. (2001). The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction.
  45. (2000). The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain.
  46. (1996). The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability.
  47. (2010). The molecular interaction of CAR and JAML recruits the central cell signal transducer PI3K.
  48. (2007). The role of junctional adhesion molecules in vascular inflammation.
  49. (2002). The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors.
  50. (2008). The tight junction protein CAR regulates cardiac conduction and cell-cell communication.
  51. (2009). Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects Phenotypes in CAR-Depleted